Print this article

Enrico Zodio – Chief Executive Officer, Procos

Keywords: ,

e-version image

Click HERE to download the PDF version

 


WHICH IS THE CORE BUSINESS OF YOUR COMPANY?

Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry.

HPAPI HAVE A FUNDAMENTAL ROLE IN THE CHEMICAL-PHARMACEUTICAL SECTOR. WHICH ARE THE ONES MANUFACTURED AT PROCOS?

Procos has already been active as custom development manufacturing company of small molecules with a capacity of over 500 m3 since many years. We offer our services to pharma companies, from synthesis and analytical development to cGMP manufacturing at any scale (from hundreds grams to multitons) with our multip ... ...